| PACKAGING TYPE: | 5x1x4 Alu-alu (5 Monocarton In 1 Box) |
| COMPOSITION: | Voriconazole 200mg Tablet |
| FORMULATION: | Tablet |
| Description: | VORITAL-200 Tablet contains Voriconazole 200mg, a broad-spectrum antifungal medication used for the treatment of serious fungal infections. It belongs to the triazole class of antifungals, which works by inhibiting fungal cell membrane synthesis, leading to the death of susceptible fungi. VORITAL-200 is prescribed for conditions such as invasive aspergillosis, candidemia, serious Candida infections, and other systemic fungal infections. |
| Side Effects: | Common side effects: Nausea or vomiting Diarrhea Headache Visual disturbances (blurred vision, changes in color perception) Serious (rare) side effects: Liver toxicity (elevated liver enzymes) Allergic reactions Severe skin reactions Cardiac arrhythmias in rare cases |
| How to Use: | Take the tablet exactly as prescribed by your doctor Usually administered twice daily for adults, dosage may vary depending on infection severity Swallow the tablet whole with water Avoid missing doses to maintain therapeutic levels Regular liver function monitoring is recommended during therapy |
| Precaution: | Monitor liver function during treatment Use cautiously in patients with kidney or liver impairment Inform your doctor about all medications to avoid drug interactions Avoid pregnancy and breastfeeding unless prescribed Regular monitoring is essential for long-term therapy |
| Product Benefits: | Effective against a wide range of fungal infections Treats invasive and systemic fungal infections Inhibits fungal growth by blocking ergosterol synthesis Suitable for use in immunocompromised patients Oral formulation allows for convenient administra |
Frequently Asked Questions
It is used to treat serious fungal infections including invasive aspergillosis and candidemia.
Voriconazole inhibits fungal cell membrane synthesis by blocking ergosterol formation, killing or stopping the growth of fungi.
Yes, it is often prescribed for immunocompromised patients who are at higher risk of systemic fungal infections.










